Nu Skin Enterprises, Inc.
NUS
$8.48
-$0.09-1.05%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -16.89% | -15.33% | -12.06% | -12.66% | -8.82% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -16.89% | -15.33% | -12.06% | -12.66% | -8.82% |
| Cost of Revenue | -15.10% | -16.47% | -8.72% | -4.64% | 80.96% |
| Gross Profit | -17.60% | -14.84% | -13.49% | -16.02% | -23.96% |
| SG&A Expenses | -16.63% | -17.00% | -17.09% | -16.67% | -12.26% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.16% | -16.83% | -14.43% | -12.97% | 4.30% |
| Operating Income | -26.43% | 18.71% | 29.37% | -4.67% | -65.57% |
| Income Before Tax | 131.47% | 20.27% | 120.82% | 12,125.34% | -719.66% |
| Income Tax Expenses | 117.05% | -121.72% | 146.99% | 1,557.65% | -1,160.46% |
| Earnings from Continuing Operations | 140.14% | 105.72% | 117.86% | 20,271.67% | -595.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 140.14% | 105.72% | 117.86% | 20,271.67% | -595.81% |
| EBIT | -26.43% | 18.71% | 29.37% | -4.67% | -65.57% |
| EBITDA | -24.74% | -5.12% | 5.88% | -14.47% | -56.46% |
| EPS Basic | 141.07% | 107.01% | 117.95% | 20,104.63% | -592.74% |
| Normalized Basic EPS | -137.64% | 233.49% | 214.95% | 40.62% | -68.58% |
| EPS Diluted | 138.61% | 103.59% | 117.95% | 19,914.81% | -615.11% |
| Normalized Diluted EPS | -136.64% | 227.65% | 214.59% | 38.98% | -68.54% |
| Average Basic Shares Outstanding | -2.28% | -0.62% | -0.50% | 0.46% | 0.61% |
| Average Diluted Shares Outstanding | 0.40% | 1.16% | -0.38% | 1.59% | 0.47% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | -84.62% |
| Payout Ratio | 3.43% | -0.52% | 6.57% | 1.01% | -1.03% |